Maze Therapeutics, Inc. · NASDAQ:MAZE
Alphabet Holdings LLC's stake in Maze Therapeutics, Inc. fell to 2.90% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 6, 2026
Alphabet Holdings LLC's stake in Maze Therapeutics, Inc. fell to 2.90%, 1,388,583 shares, as a passive investor on Dec 31, 2025. Filed Feb 6, 2026 (Schedule 13G/A).
- Stake
- 2.90%
- Shares
- 1,388,583
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GV 2019, L.P. | 1.60% | 784,019 |
| GV 2019 GP, L.P. | 1.60% | 784,019 |
| GV 2019 GP, L.L.C. | 1.60% | 784,019 |
| GV 2023, L.P. | 1.30% | 604,564 |
| GV 2023 GP, L.P. | 1.30% | 604,564 |
| GV 2023 GP, L.L.C. | 1.30% | 604,564 |
| Alphabet Holdings LLC | 2.90% | 1,388,583 |
| XXVI Holdings Inc. | 2.90% | 1,388,583 |
| Alphabet Inc. | 2.90% | 1,388,583 |
Source
Related
- Maze Therapeutics, Inc.
- Alphabet Holdings LLC
- Maze Therapeutics, Inc. shareholders
- Schedule 13G · Alphabet Holdings LLC · May 9, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026